Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM

NCT05909826 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse
Multiple Myeloma, Refractory

Interventions

DRUG: Carfilzomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone

Sponsor

Dong-A University Hospital